Evaluation of Gait Impairment and Correlation in Patients With DCM
ConditionMyelopathy Cervical
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPusan National University Yangsan Hospital
About this trial
This study aims to evaluate gait impairment in patients with Degenerative Cervical Myelopathy (DCM) before and after surgery using an inertial measurement unit (IMU) sensor. By comparing IMU-derived gait parameters with traditional clinical assessment tools (e.g., Modified Ashworth Scale, mJOA, and GRASSP), the study seeks to determine the effectiveness and reliability of IMU sensors for assessing and monitoring gait improvement and neurological recovery in DCM patients. This study is conducted outside the United States and does not involve interventions or devices subject to U.S. FDA regulation.
Eligibility criteria
Qualifiers
Age 18 years or older.
Able to communicate and provide informed consent.
Capable of walking at least 3 meters without assistance from others or walking aids.
No prior surgical treatment for cervical myelopathy.
Disqualifiers
Presence of severe respiratory or cardiac conditions that impede safe walking.
Musculoskeletal issues, such as spinal deformities, affecting gait.
History of neurological disorders affecting gait, including peripheral nerve injury, joint stiffness, stroke, traumatic brain injury, myelitis, or Parkinson's disease.
Prior orthopedic or neurosurgical interventions that could impact gait.
Trial design
Treatments tested in this trial
- Gait Analysis Using IMU Sensor
Treatment groups
30 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov